Skip to main content
Clinical Trials/JPRN-UMIN000053067
JPRN-UMIN000053067
Completed
未知

Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus - Assessing patient satisfaction following treatment with Semaglutide injection for type 2 diabetes mellitus

Kimitsu Chuo Hospital0 sites103 target enrollmentDecember 12, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
type 2 diabetes mellitus
Sponsor
Kimitsu Chuo Hospital
Enrollment
103
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
December 12, 2023
End Date
December 31, 2022
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Kimitsu Chuo Hospital

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • Patients who do not agree to participate in the study Patients judged by the attending physician that there is no indication for Semaglutide injection

Outcomes

Primary Outcomes

Not specified

Similar Trials